Praveen Rajendran

1.4k total citations
38 papers, 1.1k citations indexed

About

Praveen Rajendran is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Praveen Rajendran has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Praveen Rajendran's work include Histone Deacetylase Inhibitors Research (16 papers), Genomics, phytochemicals, and oxidative stress (7 papers) and Protein Degradation and Inhibitors (6 papers). Praveen Rajendran is often cited by papers focused on Histone Deacetylase Inhibitors Research (16 papers), Genomics, phytochemicals, and oxidative stress (7 papers) and Protein Degradation and Inhibitors (6 papers). Praveen Rajendran collaborates with scholars based in United States, India and China. Praveen Rajendran's co-authors include Roderick H. Dashwood, David E. Williams, Emily Ho, Wan Mohaiza Dashwood, Manu Jaggi, Anand C. Burman, Christiane V. Löhr, Rama Mukherjee, Tianwei Yu and William H. Bisson and has published in prestigious journals such as Cancer Research, International Journal of Cancer and Nutrients.

In The Last Decade

Praveen Rajendran

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Praveen Rajendran United States 17 907 152 141 111 72 38 1.1k
Wan Mohaiza Dashwood United States 19 889 1.0× 176 1.2× 100 0.7× 238 2.1× 78 1.1× 29 1.2k
Ka Lung Cheung United States 12 825 0.9× 86 0.6× 100 0.7× 64 0.6× 87 1.2× 16 971
Xian-Zhong Ding United States 10 450 0.5× 168 1.1× 81 0.6× 192 1.7× 68 0.9× 10 782
Lalitha Ramachandran Singapore 8 557 0.6× 197 1.3× 92 0.7× 203 1.8× 60 0.8× 11 1.0k
Jubo Wang China 18 799 0.9× 280 1.8× 151 1.1× 204 1.8× 51 0.7× 52 1.2k
Lokesh Dalasanur Nagaprashantha United States 15 581 0.6× 164 1.1× 62 0.4× 115 1.0× 122 1.7× 23 961
KM Wahidur Rahman United States 12 597 0.7× 142 0.9× 228 1.6× 157 1.4× 26 0.4× 15 873
Qunyi Li China 19 478 0.5× 96 0.6× 89 0.6× 105 0.9× 38 0.5× 54 829
Chieh-Yu Peng Taiwan 17 430 0.5× 83 0.5× 165 1.2× 104 0.9× 65 0.9× 26 762
Ling Zhi Wang Singapore 9 407 0.4× 274 1.8× 98 0.7× 124 1.1× 70 1.0× 11 740

Countries citing papers authored by Praveen Rajendran

Since Specialization
Citations

This map shows the geographic impact of Praveen Rajendran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Praveen Rajendran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Praveen Rajendran more than expected).

Fields of papers citing papers by Praveen Rajendran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Praveen Rajendran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Praveen Rajendran. The network helps show where Praveen Rajendran may publish in the future.

Co-authorship network of co-authors of Praveen Rajendran

This figure shows the co-authorship network connecting the top 25 collaborators of Praveen Rajendran. A scholar is included among the top collaborators of Praveen Rajendran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Praveen Rajendran. Praveen Rajendran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dashwood, Wan Mohaiza, et al.. (2024). Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors. Nutrients. 16(3). 396–396. 5 indexed citations
2.
Dashwood, Roderick H., et al.. (2024). A–Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer. Cancers. 16(6). 1104–1104. 4 indexed citations
3.
Zhang, Shilan, et al.. (2024). Epigenetic regulation of major histocompatibility complexes in gastrointestinal malignancies and the potential for clinical interception. Clinical Epigenetics. 16(1). 83–83. 7 indexed citations
4.
Zhang, Shilan, Chakrapani Tripathi, Wan Mohaiza Dashwood, et al.. (2023). Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis. npj Precision Oncology. 7(1). 20–20. 2 indexed citations
5.
Rajendran, Praveen, Wan Mohaiza Dashwood, Michelle I. Savage, et al.. (2020). Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP). Cancer Prevention Research. 14(3). 325–336. 12 indexed citations
6.
Rajagopal, Sridharan, D. Prabhu, Praveen Rajendran, et al.. (2015). Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts. European Journal of Medicinal Chemistry. 108. 274–286. 7 indexed citations
7.
Dashwood, Wan‐Mohaiza, et al.. (2015). Development of a murine colonoscopic polypectomy model (with videos). Gastrointestinal Endoscopy. 83(6). 1272–1276. 4 indexed citations
8.
Kim, Eunah, William H. Bisson, Christiane V. Löhr, et al.. (2015). Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors. Current Topics in Medicinal Chemistry. 16(7). 714–731. 61 indexed citations
9.
Nian, Hui, Praveen Rajendran, Wan Mohaiza Dashwood, et al.. (2014). HDAC8 and STAT3 repress BMF gene activity in colon cancer cells. Cell Death and Disease. 5(10). e1476–e1476. 65 indexed citations
10.
Gopalan, Balasubramanian, et al.. (2013). Discovery of adamantane based highly potent HDAC inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(9). 2532–2537. 39 indexed citations
11.
Rajendran, Praveen, Emily Ho, David E. Williams, & Roderick H. Dashwood. (2011). Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clinical Epigenetics. 3(1). 4–4. 164 indexed citations
12.
Rajendran, Praveen, David E. Williams, Emily Ho, & Roderick H. Dashwood. (2011). Metabolism as a key to histone deacetylase inhibition. Critical Reviews in Biochemistry and Molecular Biology. 46(3). 181–199. 61 indexed citations
13.
Rajendran, Praveen, Barbara Delage, Wan Mohaiza Dashwood, et al.. (2011). Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Molecular Cancer. 10(1). 68–68. 109 indexed citations
14.
Sinha, Barij Nayan, Philipp Saiko, Thomas Szekeres, et al.. (2010). Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 20(13). 3906–3910. 43 indexed citations
15.
Singh, Anu, Manu Jaggi, S. Prasad, et al.. (2008). Modulation of key signal transduction molecules by a novel peptide combination effective for the treatment of gastrointestinal carcinomas. Investigational New Drugs. 26(6). 505–516. 3 indexed citations
16.
Rajendran, Praveen, Manu Jaggi, Manoj Kumar Singh, Rama Mukherjee, & Anand C. Burman. (2007). Pharmacological evaluation of C-3 modified Betulinic acid derivatives with potent anticancer activity. Investigational New Drugs. 26(1). 25–34. 60 indexed citations
17.
Prasad, S., Neena Gupta, Manu Jaggi, et al.. (2006). Bombesin analogs containing α‐amino‐isobutyric acid with potent anticancer activity. Journal of Peptide Science. 13(1). 54–62. 6 indexed citations
18.
Mukherjee, Rama, Manu Jaggi, Jamshed Siddiqui, et al.. (2004). Synthesis and cytotoxic activity of 3-O-acyl/3-hydrazine /2-bromo/20,29-dibromo betulinic acid derivatives. Bioorganic & Medicinal Chemistry Letters. 14(15). 4087–4091. 28 indexed citations
19.
Mukherjee, Rama, Manu Jaggi, Praveen Rajendran, et al.. (2004). Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/3-hydrazine/17-carboxyacryloyl ester derivatives of betulinic acid as anti-angiogenic agents. Bioorganic & Medicinal Chemistry Letters. 14(12). 3169–3172. 29 indexed citations
20.
Mukherjee, Rama, Manu Jaggi, Praveen Rajendran, et al.. (2004). Betulinic acid and its derivatives as anti-angiogenic agents. Bioorganic & Medicinal Chemistry Letters. 14(9). 2181–2184. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wan Mohaiza Dashwood Breakdown of academic impact, for papers by Ka Lung Cheung Breakdown of academic impact, for papers by Xian-Zhong Ding Breakdown of academic impact, for papers by Lalitha Ramachandran Breakdown of academic impact, for papers by Jubo Wang Breakdown of academic impact, for papers by Lokesh Dalasanur Nagaprashantha Breakdown of academic impact, for papers by KM Wahidur Rahman Breakdown of academic impact, for papers by Qunyi Li Breakdown of academic impact, for papers by Chieh-Yu Peng Breakdown of academic impact, for papers by Ling Zhi Wang
Rankless by CCL
2026